Eli Lilly pauses trial of antibody drug for COVID-19 over safety concern
The company had said earlier this month that it was applying for EUA for the antibody-drug, LY-CoV555, for patients with mild to…
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.